Relationship between cervical disease and infection with human papillomavirus types 16 and 18, and herpes simplex virus 1 and 2

Journal of Medical Virology

Volumn 84, Issue 12, 2012, Pages 1920-1927

  Zhao, Youyun ^a,b   Cao, Xuan ^a   Zheng, Yi ^b   Tang, Jingfeng ^a   Cai, Wangxi ^b   Wang, Hanmin ^b   Gao, Yinglin ^b   Wang, Yefu ^a  

^a WUHAN UNIVERSITY   (China)

^b HUBEI UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Cervical cancer; Herpes simplex virus type 1; Herpes simplex virus type 2; Human papillomavirus; Triplex real time PCR assay

Indexed keywords

ADULT; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PREVALENCE; UTERINE CERVICITIS; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CERVICAL INTRAEPITHELIAL NEOPLASIA; COINFECTION; DNA, VIRAL; FEMALE; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; MIDDLE AGED; ODDS RATIO; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; RISK FACTORS; UTERINE CERVICAL NEOPLASMS; UTERINE CERVICITIS;

EID: 84867703983     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23353     Document Type: Article

References (31)

1. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shan KV. 2002. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55:244-265.
2. Brinten LA. 1992. Epidemiology of cervical cancer overview. IARC Sci Publ 119:3-23.
3. Broccolo F, Drago F, Careddu AM, Foglieni C, Turbino L, Cocuzza CE, Gelmetti C, Lusso P, Rebora E, Malnati M. 2005. Additional evidence that Pityriasis rosea is associated with reactivation of human herpesvirus-6 and -7. J Invest Dermatol 124:1234-1240.
4. Danh TT, Diane P, Anita K, Eliane DF, Allégria K, Pierre D, Cosette MW, Josée DL, Philippe G, Guy A, René V, Joseph AD, Patty G, Eduardo F, Francois C. 2003. Herpes simplex virus type II is not a cofactor to human papillomavirus in cancer of the uterine cervix. Am J Obstet Gynecol 188:129-134.
5. Ferlay J, Bray F, Pisani P, Parkin D. 2004. GLOBCSN 2002: Cancer incidence, mortality and prevalence worldwide. IARC CancerBase No. 5 (version 2.0). Lyon: IARC Press.
6. Ferrers A, Baay MF, Hervrink M, Velema JP, Melchers WJ. 1997. A sero-epidemiological study of the relationship between sexually transmitted agents and cervical cancer in Honduras. Int J Cancer 73:781-785.
7. Galloway DA, McDougall JK. 1983. The oncogenic potential of herpes simplex viruses: Evidence for a "hit-and-run" mechanism. Nature 302:21-24.
8. Golijow CD, Abba MC, Mouron SA, Laguens RM, Dulot FN, Smith JS. 2005. Chlamydia trachomatis and human papillomavirus infections in cervical disease in Argentine women. Gynecol Oncol 96:181-186.
9. Guibinga GH, Coutlee F, Kessous A. 1995. Detection of herpes simplex type 2 in genital cancers: Review of the evidence. Arch STD HIV Res 9:164-179.
10. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. 1998. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 338:423-428.
11. Jensen K, Patel A, Larin A, Hoperia V, Saji M, Bauer A, Yim K, Hemming V, Vasko V. 2010. Human herpes simplex viruses in benign and malignant thyroid tumors. J Pathol 221:193-200.
12. Luis OP, Gisela B, Martin CA, Ruben ML, Fernando ND. 2006. Herpes simplex virus and human papillomavirus infection in cervical disease in Argentine women. Int J Gynecol Pathol 25:42-47.
13. Mahjour SB, Ghaffarpasand F, Fattahi MJ, Ghaderi A, Fotouhi GA, Karimi M. 2010. Seroprevalence of human herpes simplex, hepatitis B and epstein-barr viruses in children with acute lymphoblastic leukemia in southern Iran. Pathol Oncol Res 16:579-582.
14. Manavi K, McMillan A, Ogilvie M. 2004. Herpes simplex virus type 1 remains the principal cause of initial anogenital herpes in Edinburgh, Scotland. Sex Transm Dis 31:322-324.
15. Melo A, Roa I, Montenegro S, Capurro I, Roa JC. 2005. Detection of human papillomavirus in cytologic samples or biopsies of the cervix. Rev Med Chile 133:639-644.
16. Munoz N, Kato I, Bosch FX, Sanjose SD, Sundquist VA, Izarzugaza I, Gonzalez LC, Tafur L, Gili M, Viladiu P, Navarro C, Moreo P, Guerrero E, Shah KV, Walhren B. 1995. Cervical cancer and herpes simplex virus type2: Case-control studies in Spain and Colombia, with special reference to immunoglobulin-G subclasses. Int J Cancer 60:438-442.
17. Munoz N, Bosch FX, Castellsague X, Diaz M, de Sanjose S, Hammouda D, Shah KV, Meijer CJ. 2004. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 111:278-285.
18. Ncervical cancerN Clinical Practice, Guidelines in Oncology (Ncervical cancerN Guidelines™) Cervical Cancer Screening. Version 1.2011. Ncervical cancerN.org.
19. Peng HQ, Liu SL, Mann V, Rawls W. 1991. Human papillamavirus types 16 and 33, herpes simplex virus type 2 and other risk factors for cervical cancer in Sichuan Province, China. Int J Cancer 47:711-716.
20. Pierpaolo P, Daniela B, Luigi DB, Damenico O, Cartesio F, Kari S, Marco C. 2008. Co-expression of HSV 2 and Chlamydia trachomatis in HPV-positive cervical cancer and cervical intraepithelial neoplasia lesions is associated with aberrations in key intracellular pathways. Intervirology 51:230-234.
21. Rawls WE, Tompkins WA, Figueroa ME, Melnick JL. 1968. Herpes virus type 2: Association with carcinoma of the cervix. Science 161:1255-1256.
22. Sankaranarayanan R, Nene BM, Shastri SS, Jayant K, Muwonge R, Budukh AM, Hingmire S, Malvi SG, Thorat R, Kothari A, Chinoy R, Kelkar R, Kane S, Desai S, Keskar VR, Rajeshwarkar R, Panse N, Dinshaw A. 2009. HPV screening for cervical cancer in rural India. N Engl J Med 360:1385-1394.
23. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. 2007. Human papillomavirus and cervical cancer. Lancet 370:890-907.
24. Seaman WT, Andrews E, Couch M, Kojic EM, Cu-Uvin S, Palefsky J, Deal AM, Webster CJ. 2010. Detection and quantitation of HPV in genital and oral tissues and fluids by real time PCR. Virol J 7:194-211.
25. Smith JS, Herrero R, Bosetti C, Munoz N, Bosch FX, Eluf-Neto J, Castellsague X, Meijer CJ, Brule AJ, Franceschi S, Ashley R. 2002. Herpes simplex virus 2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer. J Natl Cancer Inst 94:1604-1613.
26. Sugita M, Shimizu N, Watanabe K, Mizukami M, Morio T, Sugamoto Y, Mochizuki M. 2008. Use of multiplex PCR and real-time PCR to detect human herpes virus genome in ocular fluids of patients with uveitis. Br J Ophthalmol 92:928-932.
27. Tang J, Zhou L, Liu X, Zhang C, Zhao Y, Wang Y. 2011. Novel multiplex real-time PCR system using the SNP technology for the simultaneous diagnosis of Chlamydia trachomatis, Ureaplasma parvum and Ureaplasma urealyticum and genetic typing of serovars of C. trachomatis and U. parvum in NGU. Mol Cell Probes 25:55-59.
28. Wentzensen N, Schiffman M, Dunn T, Zuna RE, Gold MA, Allen RA, Zhang R, Sherman ME, Wacholder S, Walker J, Wang SS. 2009. Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants. Int J Cancer 125:2151-2158.
29. Wilkinson DE, Weller SK. 2006. Herpes simplex virus type I disrupts the ATR-dependent DNA-damage response during lytic infection. J Cell Sci 119:2695-2703.
30. Yang YY, Koh LW, Tsai CH, Wong EF, Lin SJ, Yang cervical cancer. 2004. Correlation of viral factors with cervical in Taiwan. J Microbiol Infect 37:282-287.
31. Zereu M, Zetter CG, Cambruzzi E, Zelmanowicz A. 2007. Herpes simplex cirus type 2 and Chlamydia trachomatis in adenocarcinoma of the uterine cervix. Gynecol Onco 105:172-175.